| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
|
J Am Dent Assoc, Vol 115, No 1, 38-42.
© 1987 American Dental Association |
Clinical Trial |
A study of the effects of oral acyclovir (200 mg), administered five times per day for 5 days in 210 patients who cultured positive for herpes labialis, is made. A total of 149 patients were followed through three episodes each of herpes labialis while taking a placebo or acyclovir. Patients were evaluated for several clinical parameters, including the loss of lesion crust and reduction of the size of the area of the lesion between day 1 and day 5. Acyclovir showed a significant antiviral effect. Results show that oral acyclovir can favorably affect some parameters, but that higher doses or a "loading dose" could improve its efficacy.
This article has been cited by other articles:
|
|
 |
|
  W. Opstelten, A. K. Neven, and J. Eekhof Treatment and prevention of herpes labialis Can Fam Physician, December 1, 2008; 54(12): 1683 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A Jensen, J. D Hoehns, and C. L Squires Oral Antivirals for the Acute Treatment of Recurrent Herpes Labialis Ann. Pharmacother., April 1, 2004; 38(4): 705 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. RABORN, K. S. CHAN, and M. GRACE Treatment modalities and medication recommended by health care professionals for treating recurrent herpes labialis J Am Dent Assoc, January 1, 2004; 135(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Spruance, T. M. Jones, M. M. Blatter, M. Vargas-Cortes, J. Barber, J. Hill, D. Goldstein, and M. Schultz High-Dose, Short-Duration, Early Valacyclovir Therapy for Episodic Treatment of Cold Sores: Results of Two Randomized, Placebo-Controlled, Multicenter Studies Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1072 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. RABORN, A. Y. MARTEL, M. LASSONDE, M. A.O. LEWIS, R. BOON, S. L. SPRUANCE, and ON BEHALF OF THE WORLDWIDE TOPICAL PENCICLOVIR COL Effective treatment of herpes simplex labialis with penciclovir cream: Combined results of two trials J Am Dent Assoc, March 1, 2002; 133(3): 303 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vander Straten, D. Carrasco, P. Lee, and S. K. Tyring A Review of Antiviral Therapy for Herpes Labialis Arch Dermatol, September 1, 2001; 137(9): 1232 - 1235. [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Spruance, T. L. Rea, C. Thoming, R. Tucker, R. Saltzman, and R. Boon Penciclovir Cream for the Treatment of Herpes Simplex Labialis: A Randomized, Multicenter, Double-blind, Placebo-Controlled Trial JAMA, May 7, 1997; 277(17): 1374 - 1379. [Abstract] [PDF]
|
|
|
|
|
|
S. L. Spruance, M. L. Hamill, W. S. Hoge, L. G. Davis, and J. Mills Acyclovir Prevents Reactivation of Herpes Simplex Labialis in Skiers JAMA, September 16, 1988; 260(11): 1597 - 1599. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
